A TritonX-100-split Virion Influenza Vaccine is Safe and Fulfills the Committee for Proprietary Medicinal Products (CPMP) Recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly

This publication has 19 references indexed in Scilit:

• Protection Against Influenza After Annually Repeated Vaccination
  Archives of internal medicine (1960), 1999
• The plea against annual influenza vaccination? ‘The Hoskins' Paradox’ revisited
  Vaccine, 1998
• Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly
  Vaccine, 1997
• Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults
  Vaccine, 1996
• The Effectiveness of Vaccination against Influenza in Healthy, Working Adults
  New England Journal of Medicine, 1995
• Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
  The Lancet, 1995
• Epidemiology of Viral Infections and Evaluation of the Potential Benefit of OM-85 BV on the Virologie Status of Children Attending Day-Care Centers
  Respiration, 1994
• Frequency of Adverse Reactions to Influenza Vaccine in the Elderly
  JAMA, 1990
• Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus
  Antimicrobial Agents and Chemotherapy, 1987
• EPIDEMIOLOGY OF INFLUENZA IN MAN
  British Medical Bulletin, 1979